Insulin resistance induces a segmental difference in thoracic and abdominal aorta: Differential expression of AT1 and AT2 receptors

Journal of Hypertension

Volumn 30, Issue 1, 2012, Pages 132-146

  Karpe, Pinakin Arun ^a   Gupta, Jeena ^a   Marthong, Rickey F ^a   Ramarao, Poduri ^a,b   Tikoo, Kulbhushan ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b CENTRAL UNIVERSITY OF PUNJAB   (India)

Author keywords

abdominal aorta; AT1 AT2 receptors; histone H3 phosphorylation; insulin resistance

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; HISTONE H3; MESSENGER RNA;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; VASCULAR RING; VASODILATATION; WESTERN BLOTTING;

EID: 83555172286     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834d9efe     Document Type: Article

References (38)

1. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008; 31:S262-S268.
2. Reaven G. Insulin resistance, hypertension, and coronary heart disease. J Clin Hypertens (Greenwich) 2003; 5:269-274. (Pubitemid 37098487)
3. Gaikwad AB, Gupta J, Tikoo K. Epigenetic changes and alteration of Fbn-1 and Col3A1 gene expression under hyperglycemic and hyperinsulinemic conditions. Biochem J 2010; 432:333-341.
4. Gupta J, Gaikwad AB, Tikoo K. Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, Rho kinase in type 2 diabetic nephropathy rats. J Cell Biochem 2010; 111:944-954.
5. Taylor AA. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am 2001; 30:983-997. (Pubitemid 33055271)
6. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Cur Hypertens Rep 2003; 5:155-164. (Pubitemid 38898946)
7. Schoonmaker GC, Fallet RW, Carmines PK. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus. Am J Physiol Renal Physiol 2000; 278:F302-F309. (Pubitemid 30131283)
8. Carey RM, Howell NL, Jin XH, Siragy HM. Angiotensin type 2 receptormediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001; 38:1272-1277. (Pubitemid 34033401)
9. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31:349-355.
10. Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nature Struct Molec Biol 2007; 14:1008-1016. (Pubitemid 350060343)
11. Wei Y, Mizzen CA, Cook RG, Gorovsky MA, Allis CD. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc Natl Acad Sci USA 1998; 95:7480-7484. (Pubitemid 28293278)
12. Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, et al. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell 2000; 5:917-926.
13. Zarins CK, Xu C, Glagov S. Atherosclerotic enlargement of the human abdominal aorta. Atherosclerosis 2001; 155:157-164. (Pubitemid 32167135)
14. Goldberg ID, Stemerman MB, Ransil BJ, Fuhro RL. In vivo aortic muscle cell growth kinetics. Differences between thoracic and abdominal segments after intimal injury in the rabbit. Circ Res 1980; 47:182-189. (Pubitemid 10056045)
15. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 2004; 26:327-333. (Pubitemid 38954807)
16. Arun KH, Kaul CL, Ramarao P. High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta. Pharmacol Res 2004; 50:561-568. (Pubitemid 39388967)
17. Arun KH, Kaul CL, Ramarao P. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovasc Res 2005; 65:374-386. (Pubitemid 40082479)
18. Arun KH, Kaul CL, Ramarao P. Tempol augments angiotensin II-induced AT2 receptor mediated relaxation in diabetic rat thoracic aorta. J Hypertens 2004; 22:2143-2152. (Pubitemid 39463808)
19. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 2005; 511:53-64. (Pubitemid 40380644)
20. Viswanad B, Srinivasan K, Kaul CL, Ramarao P. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 2006; 53:209-215. (Pubitemid 43247533)
21. Gaikwad AB, Viswanad B, Ramarao P. PPAR [gamma] agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 2007; 55:400-407. (Pubitemid 46584616)
22. Nakatsubo N, Kojima H, Kikuchi K, Nagoshi H, Hirata Y, Maeda D, et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett 1998; 427:263-266. (Pubitemid 28225070)
23. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Circ Res 1969; 25:677-686.
24. Asbún-Bojalil J, Castillo EF, Escalante BA, Castillo C. Does segmental difference in [alpha] 1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae? Vasc Pharmacol 2002; 38:169-175. (Pubitemid 36398277)
25. Bhattacharya I, Mundy AL, Widmer CC, Kretz M, Barton M. Regional heterogeneity of functional changes in conduit arteries after high-fat diet. Obesity 2008; 16:743-748. (Pubitemid 351465627)
26. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999; 104:925-935. (Pubitemid 29536342)
27. Lee JH, Xia S, Ragolia L. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comparat Physiol 2008; 295:R144-R154.
28. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888-1904. (Pubitemid 43739401)
29. Backlund M, Paukku K, Daviet L, De Boer RA, Valo E, Hautaniemi S, et al. Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Res 2009; 37:2346-2358.
30. Kabra DG, Gupta J, Tikoo K. Insulin induced alteration in posttranslational modifications of histone H3 under a hyperglycemic condition in L6 skeletal muscle myoblasts. Biochim Biophys Acta 2009; 1792:574-583.
31. Tikoo K, Meena RL, Kabra DG, Gaikwad AB. Change in posttranslational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. Br J Pharmacol 2008; 153:1225-1231. (Pubitemid 351415498)
32. Tikoo K, Singh K, Kabra D, Sharma V, Gaikwad A. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 2008; 42:397-404.
33. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205:2409-2417.
34. Villeneuve LM, Natarajan R. Epigenetics of diabetic complications. Expert Rev Endocrin and Metab 2010; 5:137-148.
35. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 2008; 105:9047-9052.
36. Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin IIinduced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003; 23:483-488. (Pubitemid 36337226)
37. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001; 134:865-870. (Pubitemid 33016158)
38. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004; 110:3849-3857. (Pubitemid 40023984)